Cyclerion Therapeutics (CYCN) Enterprise Value (2019 - 2025)

Cyclerion Therapeutics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$3.2 million for Q4 2025.

• In Q4 2025, Enterprise Value changed 0.25% year-over-year to -$3.2 million; the TTM figure through Dec 2025 stood at -$3.2 million (changed 0.25% YoY), while the FY2025 annual figure was -$3.2 million, changed 0.25% from the prior year.
• Enterprise Value was -$3.2 million for Q4 2025 at Cyclerion Therapeutics, up from -$4.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$2.9 million in Q3 2024 to a low of -$70.4 million in Q2 2021.
• Historically, Enterprise Value has averaged -$19.7 million across 5 years, with a median of -$7.4 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Enterprise Value jumped 82.57% in 2023, then plunged 59.05% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$54.0 million in 2021, then surged by 75.2% to -$13.4 million in 2022, then surged by 43.42% to -$7.6 million in 2023, then surged by 57.31% to -$3.2 million in 2024, then decreased by 0.25% to -$3.2 million in 2025.
• The last three Enterprise Value figures came in at -$3.2 million (Q4 2025), -$4.6 million (Q3 2025), and -$3.0 million (Q2 2025), per Business Quant data.